GENETIC LEVERAGE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GENETIC LEVERAGE
Largest movements
- Cash -€5,161
down €5,161 (-6.6%), from €78,717 to €73,556
mainly Net result for the year (-€2,816) and Trade debts (-€2,345)
- Profit (loss) carried forward -€2,816
down €2,816 (-1.5%), from -€182,193 to -€185,009
- Trade debts -€2,345
down €2,345 (-92.8%), from €2,526 to €182
- Gross operating margin +€7,862
up €7,862 (+80.0%), from -€9,821 to -€1,959
- Other operating charges -€261
down €261 (-27.8%), from €939 to €678
- Financial charges +€122
up €122 (+214%), from €57 to €179
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €78,717 | €73,556 | -€5,161 | -6.6% |
| Current assets | 29/58 | €78,717 | €73,556 | -€5,161 | -6.6% |
| Cash at bank and in hand | 54/58 | €78,717 | €73,556 | -€5,161 | -6.6% |
| Total equity and liabilities | 10/49 | €78,717 | €73,556 | -€5,161 | -6.6% |
| Equity | 10/15 | €8,928 | €6,112 | -€2,816 | -31.5% |
| Contributions | 10/11 | €6,197 | €6,197 | = | 0.0% |
| Capital | 10 | €6,197 | €6,197 | = | 0.0% |
| Issued capital | 100 | €18,592 | €18,592 | = | 0.0% |
| Uncalled capital | 101 | €12,395 | €12,395 | = | 0.0% |
| Reserves | 13 | €184,924 | €184,924 | = | 0.0% |
| Distributable reserves | 133 | €184,924 | €184,924 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€182,193 | -€185,009 | -€2,816 | -1.5% |
| Amounts payable | 17/49 | €69,789 | €67,444 | -€2,345 | -3.4% |
| Amounts payable after more than one year | 17 | €61,590 | €61,590 | = | 0.0% |
| Financial debts | 170/4 | €61,590 | €61,590 | = | 0.0% |
| Amounts payable within one year | 42/48 | €8,199 | €5,854 | -€2,345 | -28.6% |
| Trade debts | 44 | €2,526 | €182 | -€2,345 | -92.8% |
| Suppliers | 440/4 | €2,526 | €182 | -€2,345 | -92.8% |
| Other amounts payable | 47/48 | €5,673 | €5,673 | = | 0.0% |
| Other operating charges | 640/8 | €939 | €678 | -€261 | -27.8% |
| Gross operating margin | 9900 | -€9,821 | -€1,959 | +€7,862 | +80.0% |
| Operating profit (loss) | 9901 | -€10,759 | -€2,637 | +€8,122 | +75.5% |
| Financial charges | 65/66B | €57 | €179 | +€122 | +214% |
| Recurring financial charges | 65 | €57 | €179 | +€122 | +214% |
| Profit (loss) for the period before taxes | 9903 | -€10,816 | -€2,816 | +€8,000 | +74.0% |
| Profit (loss) for the period | 9904 | -€10,816 | -€2,816 | +€8,000 | +74.0% |
| Profit (loss) for the period to be appropriated | 9905 | -€10,816 | -€2,816 | +€8,000 | +74.0% |
Source: filed annual accounts (NBB), financial years ended 29 February 2024 and 28 February 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.